Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules

Charles T. Spencer(The University of Texas at El Paso), Sebastian Joyce(Walther Cancer Foundation), Pavlo Gilchuk(AstraZeneca (Japan)), William H. Hildebrand(University of Oklahoma Health Sciences Center), Andrew J. Link(Vanderbilt University), Chenoa D. Arico(The University of Texas at El Paso), Mireya Ramos(The University of Texas at El Paso), Jelena S. Bezbradica(University of Oxford), Mu Zheng(Vanderbilt University), Stephanie B. Conant(Vanderbilt University), Jennifer J. Gray(Vanderbilt University), Xinnan Niu(Vanderbilt University)
PROTEOMICS - CLINICAL APPLICATIONS
November 2, 2015
10.1002/prca.201500106
Cited by 30

Related Papers

Potently neutralizing and protective human antibodies against SARS-CoV-2
|Nature|2020|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
|Cell|2021|409